Open AccessDoes Trimethoprim-Sulfamethoxazole prophylaxis induce myelosuppression in primary immune deficiency disease patients; A retrospective, 3 groups comparative study
Author(s) -
Reem Elajez,
Sabha Nisar,
Mehdi Adeli
Publication year - 2020
Publication title -
asian pacific journal of allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.405
H-Index - 33
ISSN - 0125-877X
DOI - 10.12932/ap-050320-0782
Subject(s) - medicine , gastroenterology , sulfamethoxazole , trimethoprim , retrospective cohort study , urinary system , platelet , immune system , antibiotics , immunology , microbiology and biotechnology , biology
The possible myelosuppression side effect of Trimethoprim-Sulfamethoxazole (TMP-SMX) on primary immune deficiency (PID) patients has not been established yet.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom